Global Acute Heart Failure (AHF) Therapeutics Market Study 2016-2026, by Segment (B-Blockers, Calcium Channel Blockers, … …), by Market (Hospital, Clinic, … …), by Company (Bayer AG, Bristol-Myers Squibb Company, … …)
SKU ID :99ST-14740719 | Published Date: 21-Sep-2019 | No. of pages: 47Description
Summary
The global Acute Heart Failure (AHF) Therapeutics market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospital
Clinic
Home Care
Company Coverage (Sales data, Main Products & Services etc.):
Bayer AG
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Cytokinetics, Inc.
Merck & Co.
Novartis AG
Orion Corporation
PhaseBio Pharmaceuticals, Inc
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Acute Heart Failure (AHF) Therapeutics market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospital
Clinic
Home Care
Company Coverage (Sales data, Main Products & Services etc.):
Bayer AG
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Cytokinetics, Inc.
Merck & Co.
Novartis AG
Orion Corporation
PhaseBio Pharmaceuticals, Inc
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now